Literature DB >> 16802327

Pre- and postnatal findings in trisomy 17 mosaicism.

Barbara Utermann1, Mariluce Riegel, Dru Leistritz, Thomas Karall, Josef Wisser, Lorraine Meisner, Christine Fauth, Rosa Baldinger, Julie Johnson, Martin Erdel, Malgorzata Taralczak, Richard M Pauli, Alessandra Baumer, Albert Schinzel, Dieter Kotzot.   

Abstract

Trisomy 17 mosaicism is one of the rarest autosomal trisomies in humans. Thus far, only 23 cases have been described, most of them detected prenatally. In only five instances has mosaicism been demonstrated in lymphocytes and/or fibroblasts postnatally, and only in these have multiple congenital anomalies (MCA), facial dysmorphisms, and mental retardation been reported. Patients with trisomy 17 mosaicism at amniocentesis and a normal karyotype in blood and fibroblasts (n = 17) were always healthy. Here, we report on pre- and postnatal clinical, cytogenetic, molecular-cytogenetic, and molecular findings in four patients with trisomy 17 mosaicism. The first case was detected in cultured but not in short-term chorionic villi and amniocytes. Due to MCA on prenatal ultrasound examination the pregnancy was terminated. The second patient is a 13-month-old healthy boy, in whom low level trisomy 17 mosaicism was detected in cultured chorionic villi only. The third patient is a 2-year-old girl with growth retardation, developmental delay, MCA, and trisomy 17 mosaicism in amniocytes, fibroblasts, and placenta, but not in blood and buccal smear. The fourth patient is a 9-year-old boy with growth and mental retardation, sensoneurinal hearing loss, and MCA. Cytogenetic analyses showed trisomy 17 mosaicism in amniocytes, skin fibroblasts, and urinary sediment cells, whereas in blood and buccal smear a 46,XY karyotype was found. Molecular investigations in all four cases indicated biparental inheritance of chromosome 17. Formation of trisomy was most likely due to a maternal meiosis I error in Patient 1 and a postzygotic non-disjunction of the paternal chromosome 17 in Patient 4. Cerebellar malformations, reported in two cases from the literature and in two reported here may be a specific feature of trisomy 17 mosaicism. Since the aberration has rarely been reported in lymphocytes, chordocentesis is not indicated in prenatal diagnosis. Prenatal genetic counseling for trisomy 17 mosaicism in chorionic villi or amniocytes should consider that the clinical significance remains uncertain. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2006        PMID: 16802327     DOI: 10.1002/ajmg.a.31319

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  3 in total

Review 1.  Constitutional and acquired autosomal aneuploidy.

Authors:  Colleen Jackson-Cook
Journal:  Clin Lab Med       Date:  2011-12       Impact factor: 1.935

2.  Mosaic trisomy 17: variable clinical and cytogenetic presentation.

Authors:  Robert Daber; Kimberly A Chapman; Eduardo Ruchelli; Stefanie Kasperski; Surabhi Mulchandani; Brian D Thiel; Hakon Hakonarson; Elaine H Zackai; Laura K Conlin; Nancy B Spinner
Journal:  Am J Med Genet A       Date:  2011-10       Impact factor: 2.802

3.  Rare case of live born with confirmed mosaic trisomy 17 and review of the literature.

Authors:  Austin Baltensperger; Gayle Haischer; Luis Rohena
Journal:  Clin Case Rep       Date:  2016-03-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.